A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

Chimeric antigen receptor (CAR-T) cell therapy is a rapidly growing frontier in cancer research, with Australian biotech ...

The 77-year-old former breakfast TV host confirmed he was battling prostate cancer in August 2023 and has since been ...

BBC presenter Nick Owen has reflected on his cancer diagnosis calling it “the worst day of my life”. The 77-year-old news ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

The TV presenter, known for hosting Good Morning Britain, was diagnosed with the disease two years ago this year ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

The PSA test is currently used to identify men at higher risk of prostate cancer due to age, ethnicity, or symptoms. However, ...

BBC presenter Nick Owen has shared an emotional update on his battle with cancer. The former TV-am host, 77, has opened up on ...

CAR T-cell therapy reprograms a patient's immune cells to target and destroy cancer cells, offering a promising treatment for ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...